151 related articles for article (PubMed ID: 35060511)
21. [Prognosis analysis of primary breast diffuse large B cell lymphoma].
Zhu YH; Meng WJ; He LH; Jia YS; Tong ZS
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):235-240. PubMed ID: 30917462
[No Abstract] [Full Text] [Related]
22. Splenic marginal zone lymphoma: clinical characteristics and prognostic factors in a series of 60 patients.
Chacón JI; Mollejo M; Muñoz E; Algara P; Mateo M; Lopez L; Andrade J; Carbonero IG; Martínez B; Piris MA; Cruz MA
Blood; 2002 Sep; 100(5):1648-54. PubMed ID: 12176884
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology and prognostic indicators in laryngeal lymphoma: A population-based analysis.
Hong SA; Tajudeen BA; Choi S; Husain IA
Laryngoscope; 2018 Sep; 128(9):2044-2049. PubMed ID: 29392765
[TBL] [Abstract][Full Text] [Related]
24. Comparison of survival outcomes of different treatment modalities for patients with primary splenic diffuse large B cell lymphoma.
Yonghao O; Yongyang W; Siqing Y; Lihua C; Shuju T
Ann Hematol; 2023 Jul; 102(7):1857-1865. PubMed ID: 37188977
[TBL] [Abstract][Full Text] [Related]
25. Epidemiology, outcomes, and prognostic factors of orbital lymphoma in the United States.
Ahmed OM; Ma AK; Ahmed TM; Pointdujour-Lim R
Orbit; 2020 Dec; 39(6):397-402. PubMed ID: 31894706
[TBL] [Abstract][Full Text] [Related]
26. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
[TBL] [Abstract][Full Text] [Related]
27. Multi-Database Description of Primary Splenic Diffuse Large B-Cell Lymphoma.
Byrd KP; Vontela NR; McCullar B; Martin MG
Anticancer Res; 2017 Dec; 37(12):6839-6843. PubMed ID: 29187463
[TBL] [Abstract][Full Text] [Related]
28. Treatment Outcomes and Prognostic Factors in Male Patients With Stage IV Breast Cancer: A Population-based Study.
Chen W; Huang Y; Lewis GD; Szeja SS; Hatch SS; Farach A; Miltenburg D; Butler EB; Chang JC; Teh BS
Clin Breast Cancer; 2018 Feb; 18(1):e97-e105. PubMed ID: 28888581
[TBL] [Abstract][Full Text] [Related]
29. [Characteristics and outcomes of primary angiosarcoma].
Zhang ZY; Cheng YJ; Gong XL; Ge YP; Bai CM; Wang XJ; Miao Q; Zhang FQ
Zhonghua Zhong Liu Za Zhi; 2019 Sep; 41(9):693-697. PubMed ID: 31550860
[No Abstract] [Full Text] [Related]
30. Prognostic evaluation models for primary thyroid lymphoma, based on the SEER database and an external validation cohort.
Zhu Y; Yang S; He X
J Endocrinol Invest; 2022 Apr; 45(4):815-824. PubMed ID: 34865184
[TBL] [Abstract][Full Text] [Related]
31. Splenic marginal zone lymphoma: Prognostic factors, role of watch and wait policy, and other therapeutic approaches in the rituximab era.
Perrone S; D'Elia GM; Annechini G; Ferretti A; Tosti ME; Foà R; Pulsoni A
Leuk Res; 2016 May; 44():53-60. PubMed ID: 27030961
[TBL] [Abstract][Full Text] [Related]
32. Conjunctival Lymphoma--An International Multicenter Retrospective Study.
Kirkegaard MM; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Toft PB; Vemuganti GK; Thuro BA; Curtin J; Heegaard S
JAMA Ophthalmol; 2016 Apr; 134(4):406-14. PubMed ID: 26891973
[TBL] [Abstract][Full Text] [Related]
33. Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.
Madden NA; Macdonald OK; Call JA; Schomas DA; Lee CM; Patel S
Am J Clin Oncol; 2016 Oct; 39(5):458-62. PubMed ID: 24781343
[TBL] [Abstract][Full Text] [Related]
34. Improved Survival With Radiation Therapy in Stage I-II Primary Mediastinal B Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis.
Jackson MW; Rusthoven CG; Jones BL; Kamdar M; Rabinovitch R
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):126-132. PubMed ID: 26547384
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological Features, Treatment Strategy, and Prognosis of Primary Non-Hodgkin's Lymphoma of the Duodenum: A SEER Database Analysis.
Zheng G; Wang Y; Zhao Y; Zheng Z
Can J Gastroenterol Hepatol; 2020; 2020():9327868. PubMed ID: 32399459
[TBL] [Abstract][Full Text] [Related]
36. Outcomes in splenic marginal zone lymphoma: analysis of 107 patients treated in British Columbia.
Xing KH; Kahlon A; Skinnider BF; Connors JM; Gascoyne RD; Sehn LH; Savage KJ; Slack GW; Shenkier TN; Klasa R; Gerrie AS; Villa D
Br J Haematol; 2015 May; 169(4):520-7. PubMed ID: 25854936
[TBL] [Abstract][Full Text] [Related]
37. Survival Outcomes of Patients with Primary Breast Cancer Following Primary Ovarian Cancer.
Zhang W; Zhang W; Lin Z; Wang F; Li M; Zhu L; Yu Y; Gao Y
Med Sci Monit; 2019 May; 25():3869-3879. PubMed ID: 31125329
[TBL] [Abstract][Full Text] [Related]
38. Primary renal lymphoma: A population-based analysis using the SEER program (1973-2015).
Taneja A; Kumar V; Chandra AB
Eur J Haematol; 2020 May; 104(5):390-399. PubMed ID: 31769538
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors for primary diff use large B-cell lymphoma of the brain.
Zhou Z; Chen J
Asian J Surg; 2023 Oct; 46(10):4357-4362. PubMed ID: 36535876
[TBL] [Abstract][Full Text] [Related]
40. Epidemiology of Nasopharyngeal Lymphoma in the United States: A Population-Based Analysis of 1119 Cases.
Han AY; Kuan EC; Alonso JE; Badran KW; St John MA
Otolaryngol Head Neck Surg; 2017 May; 156(5):870-876. PubMed ID: 28322119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
